胃炎散颗粒治疗肝胃不和型慢性浅表性胃炎临床疗效研究

Research on clinical effect of Gastritis drug granule on treating in -coordination between liver and stomach syndrome of chronic superficial gastritis

目的：探讨胃炎散颗粒治疗肝胃不和型慢性浅表性胃炎的疗效及安全性。方法将64例肝胃不和型慢性浅表性胃炎患者，按数字表法随机分为治疗组32例和对照组计32例，治疗组口服胃炎散颗粒；对照组口服替普瑞酮胶囊。两组均以8周为1个疗程。比较两组疗效及不良反应。结果治疗组总有效率为90．6％，明显优于对照组的84．4％，差异有统计学意义（χ2＝2．015，P ＜0．05）。两组均无严重不良反应。结论胃炎散颗粒治疗肝胃不和型慢性浅表性胃炎疗效确切，安全且无任何不良反应。

Objective To explore the clinical effect and safety of Gastritis drug granule on treating in -coor-dination between liver and stomach syndrome of chronic superficial gastritis.Methods According to the digital table, 64 patients with in -coordination between liver and stomach syndrome of chronic superficial gastritis were randomly divided into treatment group and control group,32 cases in each group.The treatment group was treated by Gastritis drug granule,while the control group was treated by teprenone.The treatment course was 8 weeks.The clinical efficacy and safety were compared between the two groups.Results The comprehensive effect of the treatment group was 90.6%,which was higher than 84.4% of the control group,the difference was statistically significant（χ2 =2.015, P 〈0.05）.There were no serious adverse reactions in the two groups.Conclusion Gastritis drug granule is safe and effective for curing liver and stomach syndrome of chronic superficial gastritis and can significantly improve the clinical symptoms of the CSG patients.